Abstract:Pancreatic adenocarcinoma (PDAC) is an extremely malignant tumor that is associated with low survival rates. Fisetin is a natural flavonoid that shows diverse antitumor effects, including DNA damage, in various cancers. Increasing studies have demonstrated that epigenetic modifications play critical roles in DNA-damage response. However, the epigenetic regulation mechanism of fisetin in cancers is hardly studied. RFXAP is a critical transcription factor for MHC II molecules, however, its transcriptional role in PDAC is poorly understood. The anti-PDAC effect of fisetin was measured by CCK-8, flow cytometry, xenograft tumor nude mice model. DNA-damage levels were examined by immunofluorescence. Bioinformatics analysis was used to examine the expression of RFXAP and other genes involved in DNA-damage response. ChIP sequencing was used to explore the transcriptional role of RFXAP. The expression of target gene KDM4A was measured by qRT-PCR and western blots. KDM4A promoter activity was analyzed using dual-luciferase reporter assay. RFXAP overexpressing or silencing of PDAC cells was used to explore the effect of RFXAP in DNA damage induced by fisetin. We found that fisetin inhibited cell proliferation and induced DNA damage and S-phase arrest in PDAC. Expression of RFXAP and other DNA-damage response genes were upregulated by fisetin. We revealed that RFXAP expression was relatively low in PDAC and correlated with tumor stage and poor prognosis. Then we explored the transcriptional role of RFXAP and found that RFXAP targeted KDM4A , a special demethylase specific for tri- and dimethylated histone H3K36. We found that overexpression of RFXAP upregulated KDM4A and attenuated methylation of H3K36, thereby impairing DNA repair and enhancing the DNA damage induced by fisetin, while RFXAP silencing showed the opposite effect. We also found the function of fisetin in enhancing the effect of chemotherapy on pancreatic cancer cells. Our findings revealed that fisetin induced DNA damage via RFXAP/KDM4A-dependent histone H3K36 demethylation, thus causing inhibition of proliferation in PDAC.

Fisetin Inhibits Cell Proliferation Through the Induction of G0/G1 Phase Arrest and Caspase-3-Mediated Apoptosis in Mouse Leukemia Cells.

Biological Effects and Mechanisms of Fisetin in Cancer: a Promising Anti-Cancer Agent

Fisetin Induces Apoptosis of HSC3 Human Oral Cancer Cells Through Endoplasmic Reticulum Stress and Dysfunction of Mitochondria-mediated Signaling Pathways.

Fisetin nanoparticles based on cells cycle and apoptosis intervention for the treatment of lymphoma and leukemia

Fisetin, a dietary flavonoid, induces cell cycle arrest and apoptosis through activation of p53 and inhibition of NF-kappa B pathways in bladder cancer cells.

Anti-cancer Effects of Fisetin on Mammary Carcinoma Cells Via Regulation of the PI3K/Akt/mTOR Pathway: in Vitro and in Vivo Studies

Fisetin induces G2/M phase arrest and caspase‐mediated cleavage of p21Cip1 and p27Kip1 leading to apoptosis and tumor growth inhibition in HNSCC

Anti‑cancer Effects of Fisetin on Mammary Carcinoma Cells Via Regulation of the PI3K/Akt/mTOR Pathway: Inï¿½vitro and Inï¿½vivo Studies

Fisetin Inhibits the Proliferation of Gastric Cancer Cells and Induces Apoptosis Through Suppression of ERK 1/2 Activation.

Anti‑cancer effects of fisetin on mammary carcinoma cells via regulation of the PI3K/Akt/mTOR pathway: In vitro and in vivo studies.

Fisetin Suppresses Malignant Proliferation in Human Oral Squamous Cell Carcinoma Through Inhibition of Met/Src Signaling Pathways.

The pleiotropic effects of fisetin and hesperetin on human acute promyelocytic leukemia cells are mediated through apoptosis, cell cycle arrest, and alterations in signaling networks

Fisetin Inhibited Growth and Metastasis of Triple-Negative Breast Cancer by Reversing Epithelial-to-Mesenchymal Transition via PTEN/Akt/GSK3β Signal Pathway.

Fisetin Exerts Anti-tumorigenic Activity via Inhibition of Trypsin Activity in Colorectal Cancer

Genotoxic and Cytotoxic Activity of Fisetin on Glioblastoma Cells

Fisetin‐induced Apoptosis of Human Oral Cancer SCC‐4 Cells Through Reactive Oxygen Species Production, Endoplasmic Reticulum Stress, Caspase‐, and Mitochondria‐dependent Signaling Pathways

Fisetin, a Dietary Flavonoid Induces Apoptosis Via Modulating the MAPK and PI3K/Akt Signalling Pathways in Human Osteosarcoma (U-2 OS) Cells

Fisetin inhibits proliferation of pancreatic adenocarcinoma by inducing DNA damage via RFXAP/KDM4A-dependent histone H3K36 demethylation

Fisetin Suppresses Human Osteosarcoma U-2 OS Cell Migration and Invasion Via Affecting FAK, Upa and NF-ĸB Signaling Pathway in Vitro.

Effects of Fisetin Extract on Mouse T Lymphocytes and the NO Secretion of Mouse Macrophages

Fisetin Inhibits the Proliferation, Migration and Invasion of Pancreatic Cancer by Targeting PI3K/AKT/mTOR Signaling